4
Changes in Ownership
Alaunos Therapeutics, Inc. Filed Acc 0001209191-21-054089
Chief Executive Officer acquired 875,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Boyle Kevin S. Sr. Chief Executive Officer | 2021-08-30 | Grant or award | +875,000 | 875,000 | D | ||
| Derivatives | |||||||
| Boyle Kevin S. Sr. Chief Executive Officer | 2021-08-30 | Grant or award · Employee Stock Option (right to buy) | +2,625,000 | 2,625,000 | D | ||
Loading xslF345X03/doc4.xml…